What doesn't Johnson & Johnson (NYSE:JNJ) produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
March 13 - News
As the Dow Jones Industrials continues to forge ahead to new highs, many investors have become anxious about just how long the bull-market run can last.
Keep Reading →
March 12 - News
The Motley Fool recently whittled down 1,700 public companies to name its list of The 25 Best Companies in America. Merck & Co., Inc.
Keep Reading →
March 12 - News
They say that most bull markets end with a final bout of exuberance, and that certainly looks like what might be happening with the stock market these days.
Keep Reading →
March 11 - News
Flip to the 2012 financial results for AbbVie Inc (NYSE:ABBV) and you'll see that its best-selling drug, Humira, brought in $9.27 billion in 2012, or 51% of the company's total...
Keep Reading →
March 11 - News
Cancer just might be one of the scariest words in the English language. What goes through your mind when you hear that someone close to you has cancer? Sadness, probably.
Keep Reading →
March 11 - News
That's hardly the most shocking statistic of the obesity epidemic, America's most serious ongoing crisis.
Keep Reading →
March 10 - News
For three days running, the Dow Jones Industrials have set new all-time record highs.
Keep Reading →
March 8 - News
Investing in the health care sector isn't easy.
Keep Reading →
March 7 - News
Markets aren't screaming higher today, but a slightly better-than-expected reading of jobless claims in the U.S. has still pushed stocks higher for the day.
Keep Reading →
March 7 - News
A common trap many investors fall into is becoming overly confident in their views. This leads to wagering too much on a single outcome.
Keep Reading →
March 7 - News
The markets are back on the upswing today as the Dow Jones Industrial Average continues to push on to uncharted highs. As of 2:15 p.m.
Keep Reading →
March 7 - News
"There are many reasons for an insider to sell a stock, but only one to buy it: he expects to make money." So goes the saying.
Keep Reading →
March 7 - News
Are we beating up too much on Eli Lilly & Co.
Keep Reading →
March 6 - News
Bio-based enzyme producer Codexis, Inc. (NASDAQ:CDXS) reported financial results for the fourth quarter and full-year 2012 last week.
Keep Reading →
March 5 - News
Most fund managers, if you asked them in private, would likely concede that buying a 30 year bond with a yield that is less than inflation is not an ideal long term investing ...
Keep Reading →
March 5 - News
Gilead Sciences, Inc. (NASDAQ:GILD)' sofosbuvir with Johnson & Johnson (NYSE:JNJ) and Medivir's simeprevir are a match made in heaven.
Keep Reading →
March 5 - News
Today's surge has brought the Dow Jones Industrial Average (Dow Jones Indices: .DJI) to a new nominal all-time high, surpassing the mark it reached on Oct. 9, 2007.
Keep Reading →
March 5 - News
Investors are always trying to find the right balance between risk andreward.
Keep Reading →
March 4 - News
If you don't religiously follow the markets and are just seeing the weekly results for the first time, it would appear that this past week was simply a slight winner and nothing...
Keep Reading →
March 4 - News
Dow-30 component Johnson & Johnson (NYSE:JNJ) is a giant healthcare company, with exposure to the consumer products, medical devices, and pharmaceuticals arenas.
Keep Reading →
February 25 - News
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company ...
Keep Reading →
February 25 - Dividend Stocks
A quick glance at the markets a week ago and today might have you thinking it was a quiet week on Wall Street.
Keep Reading →
February 24 - News
Although spin-off situations offered investors compelling investment opportunities most of the time, investors should study each situation quite carefully to determine its own...
Keep Reading →
February 22 - News
Merck & Co., Inc. (NYSE:MRK) has to more heavily rely on top selling pharmaceuticals now that Singulair's off patent.
Keep Reading →
February 22 - News
It's always the case. As an investment broker I had clients every week asking about treasuries.
Keep Reading →
February 22 - News
I admit it's sometimes difficult to look too far down the road when the market continues to head higher regardless of the economic news.
Keep Reading →
February 22 - News
Analysts wonder if other drug companies will follow in the footsteps of Abbott Laboratories (NYSE:ABT) and spinoff different parts of their business.
Keep Reading →
February 21 - News
Stock buybacks are generally considered a bullish signal on Wall Street.
Keep Reading →
February 21 - News
I've been examining dividend stocks for nearly a year now, selecting what I feel are the absolute best for my own dividend portfolio.
Keep Reading →
February 21 - News
Yesterday, the Dow Jones Industrial Average closed just 128 points below its all-time high, while the S&P 500 ended the day just 35 points short of its own record.
Keep Reading →
February 21 - News
Just when the markets seem to start humming along smoothly and lulling investors into a false sense of security, a day like today sneaks up and catches investors off-guard.
Keep Reading →
February 20 - News
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Keep Reading →
February 20 - News
Seems like every day now the Dow Jones Industrial Average is touching a new yearly high. As of 2:25 p.m.
Keep Reading →
February 20 - News
Neither company has a stellar track record when it comes to dividends.
Keep Reading →
February 19 - Dividend Stocks
Gilead Sciences, Inc. (NASDAQ:GILD) is the world’s largest maker of HIV drugs, but has taken on a number of new initiatives to enter other areas of treatment.
Keep Reading →
February 19 - News
Make no bones about it -- Zoetis Inc (NYSE:ZTS) is one expensive stock. It even might be the most expensive health-care stock for its size.
Keep Reading →
February 19 - News
It's now more than halfway through the period that Eli Lilly & Co. (NYSE:LLY) has called its "years YZ," a term describing the years spanning from 2011 to 2014.
Keep Reading →
February 19 - News
Just as we examine companies each week that may be rising past their fair value, we can also find companies potentially trading at bargain prices.
Keep Reading →
February 19 - News
Pfizer Inc. (NYSE:PFE) faced a rough 2012 after Lipitor's loss of exclusivity in November 2011.
Keep Reading →
February 18 - News
Research firm Decision Resources predicts that the rheumatoid arthritis market will modestly grow to $15 billion in the next decade.
Keep Reading →
February 18 - News
Pfizer Inc. (NYSE:PFE) recently spun off animal health firm Zoetis Inc (NYSE:ZTS) in the form of an IPO.
Keep Reading →
February 15 - News
Merck & Co., Inc. (NYSE:MRK) lost blockbuster asthma drug Singulair off the patent cliff last year, and the sales plunge quickly followed.
Keep Reading →
February 15 - News
The Dow Jones Industrial Average is pulling back once again after yesterday's surge, falling just below the 14,000 mark it has flirted with over the past few weeks.
Keep Reading →
February 14 - News
Hedge funds and other major investors continue to file their 13Fs for the fourth quarter of 2012 this week, disclosing many of their long equity positions as of the end of December...
Keep Reading →
February 14 - News
While a few industries and some stocks in particular have been negatively affected by President Obama's speech last night, for the most part investors treated today like just ...
Keep Reading →
February 14 - News
Only 47 stocks in the S&P 500 currently pay a dividend yield in excess of four percentage points, and of this top decile, a little over half sport market capitalizations greater...
Keep Reading →
February 14 - Dividend Stocks
The pharmaceuticals industry has always been one of the riskiest in the market.
Keep Reading →
February 14 - News
While it may still be too early to tell, predictions that the markets would collapse after last night's State of the Union address seem to be dead wrong.
Keep Reading →
February 13 - News
